Роль хирургического лечения эпителиального рака яичников

Автор: Narendra Hulikal

Журнал: Злокачественные опухоли @malignanttumors

Статья в выпуске: 2 т.1, 2012 года.

Бесплатный доступ

Хирургический подход используется у больных эпителиальным раком яичников с целью диагностики и стадирования, радикального и паллиативного лечения. Эта статья посвящена роли хирургии в профилактике, диагностике, стадировании и лечении ранних и распространенных форм заболевания. В статье также кратко освящено паллиативное хирургическое лечение.

Эпителиальный рак яичников, хирургическое лечение

Короткий адрес: https://sciup.org/14045413

IDR: 14045413

Список литературы Роль хирургического лечения эпителиального рака яичников

Chaudhry K. Epidemiology of Cancer of Ovary: Changing Trends. Indian journal of medical & paediatric oncology. 30:suppl 1.2009.8
Permuth-Wey J., Sellers T.A. Epidemiology of ovarian cancer. Methods in Molecular Biology, 2009;472:413-437
Goff BA, Mandel LS, Drescher CW, et al. Development of an ovarian cancer symptom index: possibilities for earlier detection. Cancer. 2007;109:221-227
Menon U, Gentry-Maharaj A, Hallett R, et al. Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Lancet Oncol 2009;10:327-40
Finch A, Beiner M, Lubinski J, et al. Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation. JAMA. 2006;296:185-92
Aletti GD, Gallenberg MM,Cliby WA, Jatoi A, Hartmann LC. Current Management Strategies for Ovarian Cancer. Mayo Clin Proc. 2007;82:751-770
Kauff ND, Barakat RR. Risk-reducing salpingo-oophorectomy in patients with germline mutations in BRCA1 or BRCA2. J Clin Oncol. 2007;25:2921-7
Young RC, Decker DG, Wharton JT, et al. Staging laparotomy in early ovarian cancer. JAMA. 1983;250:3072-6
Meier WJ. Lymphadenectomy in stage I ovarian cancer. Proc Am Soc Clin Oncol 2000;19:1541
Benedetti-Panici P, Greggi S, Maneschi F, et al. Anatomical and pathological study of retroperitoneal nodes in epithelial ovarian cancer. Gynecol Oncol 1993;51:150-4
Petru E, Lahousen M, Tamussino K, et al. Lymphadenectomy in stage I ovarian cancer. Am J Obstet Gynecol 1994;170:656-62
Baiocchi G, Raspagliesi F, Grosso G, et al. Early ovarian cancer: Is there a role for systematic pelvis and para-aortic lymphadenectomy? Int J Gynecol Cancer 1998;8:103-108
Lyman GH, Khorana AA, Falanga A, et al. American Society of Clinical Oncology Guideline: Recommendations for Venous Thromboembolism Prophylaxis and Treatment in Patients with Cancer. J Clin Oncol. 2007;25:1-16
Chan JK, Urban R, Hu JM, et al. The potential therapeutic role of lymph node resection in epithelial ovarian cancer: a study of 13918 patients. Br J Cancer. 2007;96:1817-22
Maggioni A, Panici PB, Dell›Anna T, et al. Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis. Br J Cancer. 2006;95:699-704
Vergote I. Role of surgery in ovarian cancer: an update. Acta Chir Beig. 2004;104:246-56
Earle CC, Schrag D, Neville BA, et al. Effect of Surgeon Specialty on Processes of Care and Outcomes for Ovarian Cancer Patients. J Natl Cancer Inst 2006;98:172 -80
Engelen MJA., Kos HE, Willemse PHB, et al. Surgery by Consultant Gynecologic Oncologists Improves Survival in Pati nts with Ovarian Carcinoma. Cancer 2006;106:589-98
Martinek IE, Kehoe S. When Should Surgical Cytore-duction in Advanced Ovarian Cancer Take Place? J Oncol. 2010:85;20-28
Van Gorp T, Amant F, Neven P, Berteloot P, Leunen K, Vergote I. The position of neoadjuvant chemotherapy within the treatment of ovarian cancer. Minerva Ginecol. 2006;58:393-403
Horng HC, Yuan CC, Lai CR, Wang PH. Presumed Stage IA primary epithelial ovarian carcinoma: the role of complete staging surgery. Eur J Gynaecol Oncol. 2007;28:43-4
Bae J, Lim MC, Choi JH, et al. Prognostic factors of secondary cytoreductive surgery for patients with recurrent epithelial ovarian cancer. J Gynecol Oncol.2009;20:101-106
Park JY, Kim DY, Suh DS, et al. Outcomes of fertility-sparing surgery for invasive epithelial ovarian cancer: oncologic safety and reproductive outcomes. Gynecol Oncol. 2008;110:345-53
Schlaerth AC, Chi DS, Poynor EA, Barakat RR, Brown CL. Long-term survival after fertility-sparing surgery for epithelial ovarian cancer. Int J Gynecol Cancer. 2009;19:1199-204
Kesic V. Fertility after the treatment of gynecologic tumors. Recent Results Cancer Res. 2008;178:79-95
Kwon YS, Hahn SH, Kim TJ, et al. Fertility preservation in patients with early epithelial ovarian cancer. J Gynecol Oncol. 2009; 20:44-47
Canis M, Jardon K, Niro J, et al. [Endoscopic management of gynecological malignancies: an update. 2007. Bull Acad Natl Med. 2007;191:1357-65
Jung US, Lee JH, Kyung MS, Choi JS. Feasibility and efficacy of laparoscopic management of ovarian cancer. J. Obstet. Gynaecol. Res 2009;35:113-118
Park JY, Bae J, Lim MC, et al. Laparoscopic and laparotomic staging in stage I epithelial ovarian cancer: a comparison of feasibility and safety. Int J Gynecol Cancer. 2008;18:1202-9
Park JY, Kim DY, Suh DS, et al. Comparison of laparos-copy and laparotomy in surgical staging of early-stage ovarian and fallopian tubal cancer. Ann Surg Oncol. 2008;15:2012-9
Liu CS, Nagarsheth NP, Nezhat FR. Laparoscopy and ovarian cancer: a paradigm change in the management of ovarian cancer? J Minim Invasive Gynecol. 2009; 16:250-62

Еще

Статья научная